Investors are always on the lookout for the best returns, and seeking stocks with potential for great upside. At first glance, biotech stocks wouldn’t seem to be great candidates for success – they come along with high overheads and expensive product research, and long lead times before taking anything to market. But that hasn’t stopped investors from putting money into highly speculative biotech companies. The keys here are a willingness to shoulder some risk, and an understanding that success will be based not on traditional factors like earnings and sales metrics but on clinical trial results and governmental regulatory decisions.
https://www.tipranks.com/news/article/analysts-bet-on-these-2-biotech-stocks-see-over-50-upside-potential
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Sep 2021 to Oct 2021 Click Here for more Viracta Therapeutics Charts.
Viracta Therapeutics (NASDAQ:VIRX)
Historical Stock Chart
From Oct 2020 to Oct 2021 Click Here for more Viracta Therapeutics Charts.